Home » Topics » BioWorld Science

BioWorld Science
RSS

Ivermectin, approved as an antiparasitic, inhibits SARS-CoV-2 in vitro

April 6, 2020

Collaboration between UW-Madison, FluGen and Bharat Biotech to develop COVID-19 vaccine

April 6, 2020

Microbiome changes precede tumor development in CRC

April 6, 2020

Optogenetic plaque model traces neurodegeneration in AD

April 6, 2020

Novel diet-induced obese rat model of AF

April 6, 2020

Mouse model of COPD established through use of intratracheal spray

April 6, 2020

Positive interim data from phase IIb study of UGN-102

April 6, 2020

Horizon Therapeutics acquires LPA1 receptor antagonist for dcSSc

April 6, 2020

Futura Medical presents further detailed data from FM57 phase III study of MED-3000

April 6, 2020

Capricor initiates compassionate use program for patients with severe COVID-19

April 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...